November 5, 2021 | Published by bit.bio
On the left Sir Gregory Paul Winter CBE FRS FMedSci, Nobel Prize-winning British molecular biologist and bit.bio's board member, right Dr Mark Kotter Founder and CEO bit.bio
CAMBRIDGE, UK, Friday 5 November 2021 - bit.bio CEO Dr Mark Kotter was interviewed by END Points on bit.bio's $103m Series B fundraise and board appointments.
Founder and CEO
Read the full Endpoints News article.